15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisResearch in context

15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisResearch in context

Summary: Background: Standardized, high-quality PRO data reporting is crucial for patient centered care in the field of oncology, especially in clinical trials that establish standard of care. This study evaluated PRO endpoint design, conduct and reporting methods in FDA approved drugs for GU malig...

ver descrição completa

Detalhes bibliográficos
Principais autores: Mahati Paravathaneni, Houssein Safa, Vidhu Joshi, Monica K. Tamil, Jacob J. Adashek, Filip Ionescu, Savan Shah, Juskaran S. Chadha, Scott Gilbert, Brandon Manley, Adele Semaan, Heather S.L. Jim, Denise Kalos, Youngchul Kim, Philippe E. Spiess, Jad Chahoud
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2024-02-01
coleção:EClinicalMedicine
Assuntos:
Patient reported outcomes
Renal cell cancer
Prostate cancer
Urothelial cancer
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2589537023005904

Registros relacionados

Registros relacionados